Pacira BioSciences, Inc. (PCRX) — Cash Flow-to-Debt Ratio
Pacira BioSciences, Inc. (PCRX) has a Cash Flow-to-Debt Ratio of 0.10x as of June 2026, meaning its operating cash flow of $57.46 Million could theoretically repay 0% of its total liabilities ($572.01 Million) in one year. See Pacira BioSciences, Inc. (PCRX) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pacira BioSciences, Inc. Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for Pacira BioSciences, Inc. across 18 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Pacira BioSciences, Inc..
Annual Cash Flow-to-Debt Ratio for Pacira BioSciences, Inc. (2008–2025)
Year-by-year debt coverage analysis for Pacira BioSciences, Inc.. Check PCRX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.27x | $151.99 Million | $571.81 Million | ▲ +8.8% |
| 2024 | 0.24x | $189.39 Million | $775.17 Million | ▲ +11.3% |
| 2023 | 0.22x | $154.65 Million | $704.26 Million | ▲ +37.0% |
| 2022 | 0.16x | $145.27 Million | $906.19 Million | ▲ +71.5% |
| 2021 | 0.09x | $125.72 Million | $1.34 Billion | ▼ -20.5% |
| 2020 | 0.12x | $77.03 Million | $654.83 Million | ▼ -20.6% |
| 2019 | 0.15x | $70.52 Million | $476.12 Million | ▲ +11.6% |
| 2018 | 0.13x | $48.87 Million | $368.13 Million | ▲ +160.4% |
| 2017 | 0.05x | $17.79 Million | $348.89 Million | ▼ -73.7% |
| 2016 | 0.19x | $33.45 Million | $172.49 Million | ▲ +14.5% |
| 2015 | 0.17x | $29.00 Million | $171.23 Million | ▲ +3.0% |
| 2014 | 0.16x | $25.47 Million | $154.93 Million | ▲ +148.9% |
| 2013 | -0.34x | $-43.22 Million | $128.57 Million | ▲ +77.9% |
| 2012 | -1.52x | $-70.13 Million | $46.20 Million | ▼ -219.4% |
| 2011 | -0.48x | $-31.00 Million | $65.22 Million | ▼ -119.6% |
| 2010 | -0.22x | $-24.88 Million | $114.94 Million | ▲ +30.5% |
| 2009 | -0.31x | $-20.84 Million | $66.90 Million | ▲ +54.1% |
| 2008 | -0.68x | $-29.19 Million | $43.05 Million | — |